With all the talk about it in the scientific community, there is probably no surprise that this is yet another article discussing CRISPR. However, this may be one of the most profound discussions around the technology as it involves what could arguably be the potential flagship use of the gene editing tool – human therapy. Read more

Advances in gene editing technology have spurred considerable progress towards a treatment for Duchenne muscular dystrophy (DMD).  Although the disease is rare – affecting roughly 1 in 5,000 male births – its consequences are devastating: patients are confined to wheelchairs at an early age and often succumb to heart or respiratory failure in their twenties or thirties. Read more

Meet Prof. Dr. Miomir Knežević, professor at the University of Ljubljana and a founder of several biotech companies.

Miomir Kneževič

Image courtesy TSmedia, medijske vsebine in storitve, d.o.o.



“Stem cells offer new opportunities for better quality of life and also better survival of the patients.”

Read more

Meet Dr. Katerina Čeh, CEO of Animacel

Read more

Mesenchymal stromal cell use in treating severe graft-versus-host disease.

Read more